SAFETY AND EFFICACY OF ORAL AND VAGINAL MISOPROSTOL FOR INDUCTION OF LABOUR IN TERM PREGNANCIESâ??- A RANDOMISED CONTROLLED TRIAL IN A TERTIARY HEALTH CENTRE

Phase 2

• Conditions: Health Condition 1: O481- Prolonged pregnancy

• Registration Number: CTRI/2019/09/021130
• Lead Sponsor: MOSC MEDICAL COLLEGEKOLENCHERY

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 24 November 2021

Recruitment & Eligibility

• Status: Open to Recruitment
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

Nulliparous and Multiparous women at term(37-42 completed weeks of gestation with first trimester ultrasound confirmed dates),with a singleton fetus of Cephalic presentation with :

Clinically adequate pelvis

Reassuring fetal heart tracing,

,Modified bishopâ??s score of less than 6

[1]Gestational diabetes mellitus,

[2] gestational hypertension,

[3]past date,

[4]oligohydramnios,

[5]Premature rupture of membranes[ <6hours]

Are eligible for this trial

Exclusion Criteria

All patients with [1]severe systemic illnesses like uncontrolled diabetes mellitus, severe pre-eclampsia, cardiac, renal or hepatic disease,

[2] IUGR,

[3]intrauterine deaths

[4]hypersensitivity to misoprostol or any prostaglandin analogue

[5] Patients with any contraindication to induction and vaginal delivery, e.g. cephalopelvic disproportion, malpresentation, fetal compromise, non reassuring fetal heart rate pattern, previous scar and ante partum haemorrhage.

[6] Patients who are not willing to participate in this study

Study & Design

• Study Type: Interventional
• Study Design: Not specified